sodium channel, voltage-gated, type IV, beta |
SODIUM ORTHOVANADATE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
histamine receptor H 1 |
4-FLUORO-L-PHENYLALANINE |
Histamine H1, Central |
-16% |
NoneNone |
NoneNone |
View
|
Protein-tyrosine kinase, Fyn |
OXYTETRACYCLINE |
Protein Tyrosine Kinase, Fyn |
-16% |
NoneNone |
NoneNone |
View
|
matrix metalloproteinase 1 (interstitial collagenase) |
DEFERIPRONE |
Protease, Matrix Metalloprotease-1 (MMP-1) |
-16% |
NoneNone |
NoneNone |
View
|
DNA encoding receptor of vasoactive intestinal polypeptide |
DEXKETOPROFEN |
Vasoactive Intestinal Peptide VIP1 |
-16% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 2b |
KETAMINE |
Adrenergic alpha2B |
-16% |
NoneNone |
NoneNone |
View
|
progesterone receptor |
IMIQUIMOD |
Progesterone |
-16% |
NoneNone |
NoneNone |
View
|
progesterone receptor |
IMIQUIMOD |
Progesterone |
-16% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 5B |
MEROPENEM |
Serotonin 5-HT4 |
-16% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 4 |
MEROPENEM |
Serotonin 5-HT4 |
-16% |
NoneNone |
NoneNone |
View
|
lymphocyte protein tyrosine kinase (mapped) |
PYRAZINAMIDE |
Protein Tyrosine Kinase, Lck |
-16% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 3 |
D-TUBOCURARINE CHLORIDE |
Glycine, Strychnine-Sensitive |
-16% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 1 subunit |
D-TUBOCURARINE CHLORIDE |
Glycine, Strychnine-Sensitive |
-16% |
NoneNone |
NoneNone |
View
|
glycine receptor, beta subunit |
D-TUBOCURARINE CHLORIDE |
Glycine, Strychnine-Sensitive |
-16% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 2 subunit |
D-TUBOCURARINE CHLORIDE |
Glycine, Strychnine-Sensitive |
-16% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 1a |
PHYSOSTIGMINE |
Adrenergic alpha1A |
-16% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 |
CLORPRENALINE |
Cyclooxygenase COX-2 |
-16% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
CLORPRENALINE |
Cyclooxygenase COX-2 |
-16% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2A |
ENROFLOXACIN |
Serotonin 5-HT2A |
-16% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 2 |
NABUMETONE |
Chemokine CCR2B |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
MADURAMICIN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
MADURAMICIN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
MADURAMICIN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
MADURAMICIN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
MADURAMICIN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
MADURAMICIN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
MADURAMICIN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
MADURAMICIN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
MADURAMICIN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
MADURAMICIN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
MADURAMICIN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
MONOBENZONE |
Glutamate, NMDA, Agonism |
-16% |
NoneNone |
NoneNone |
View
|
N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) |
MONOBENZONE |
Glutamate, NMDA, Agonism |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B |
MONOBENZONE |
Glutamate, NMDA, Agonism |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
MONOBENZONE |
Glutamate, NMDA, Phencyclidine |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, NMDA2C |
MONOBENZONE |
Glutamate, NMDA, Phencyclidine |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
MONOBENZONE |
Glutamate, NMDA, Phencyclidine |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
MONOBENZONE |
Glutamate, NMDA, Phencyclidine |
-16% |
NoneNone |
NoneNone |
View
|
N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) |
MONOBENZONE |
Glutamate, NMDA, Phencyclidine |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B |
MONOBENZONE |
Glutamate, NMDA, Phencyclidine |
-16% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 1A |
MONOBENZONE |
Serotonin 5-HT1A |
-16% |
NoneNone |
NoneNone |
View
|
caspase 1 |
IPRONIAZID |
Protease, Caspase 1 |
-16% |
NoneNone |
NoneNone |
View
|
caspase 1, apoptosis-related cysteine protease (interleukin 1, beta, convertase) |
IPRONIAZID |
Protease, Caspase 1 |
-16% |
NoneNone |
NoneNone |
View
|
caspase 3, apoptosis related cysteine protease |
IPRONIAZID |
Protease, Caspase 1 |
-16% |
NoneNone |
NoneNone |
View
|
caspase 2 |
IPRONIAZID |
Protease, Caspase 1 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type II, beta |
FLUORESCEIN |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type II, alpha 2 |
FLUORESCEIN |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, beta |
FLUORESCEIN |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, alpha |
FLUORESCEIN |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 |
CAFFEINE |
Thromboxane Synthetase |
-16% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
CAFFEINE |
Thromboxane Synthetase |
-16% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 4 |
D-CAMPHOR |
Chemokine CCR4 |
-16% |
NoneNone |
NoneNone |
View
|
insulin receptor |
FLUOCINONIDE |
Insulin |
-16% |
NoneNone |
NoneNone |
View
|
insulin receptor |
FLUOCINONIDE |
Insulin |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type III, beta |
CROTAMITON |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, alpha |
CROTAMITON |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IX, alpha |
CROTAMITON |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type VII, alpha |
CROTAMITON |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
amiloride-sensitive cation channel 5, intestinal |
CROTAMITON |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type III, beta |
CROTAMITON |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type VIII, alpha polypeptide |
CROTAMITON |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type XI, alpha |
CROTAMITON |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, beta |
CROTAMITON |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type 10, alpha polypeptide |
CROTAMITON |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, alpha polypeptide |
CROTAMITON |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type V, alpha polypeptide |
CROTAMITON |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type II, beta |
CROTAMITON |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 alpha |
CROTAMITON |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 gamma |
CROTAMITON |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 beta |
CROTAMITON |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type 2, alpha 1 polypeptide |
CROTAMITON |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type XI, alpha |
CROTAMITON |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1, gamma |
CROTAMITON |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1, delta |
CROTAMITON |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) |
CROTAMITON |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 alpha |
CROTAMITON |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type X, alpha |
CROTAMITON |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IX, alpha |
CROTAMITON |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage gated, type VIII, alpha |
CROTAMITON |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type VII, alpha |
CROTAMITON |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) |
CROTAMITON |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, beta |
CROTAMITON |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, alpha |
CROTAMITON |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type III, alpha |
CROTAMITON |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type II, beta |
CROTAMITON |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type II, alpha 2 |
CROTAMITON |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, beta |
CROTAMITON |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
tachykinin receptor 1 |
BETAHISTINE |
Tachykinin NK1 |
-16% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase 5a, mitochondrial |
TAMOXIFEN |
Carbonic Anhydrase |
-16% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 3 |
ISONIAZID |
Glycine, Strychnine-Sensitive |
-16% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 1 subunit |
ISONIAZID |
Glycine, Strychnine-Sensitive |
-16% |
NoneNone |
NoneNone |
View
|
glycine receptor, beta subunit |
ISONIAZID |
Glycine, Strychnine-Sensitive |
-16% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 2 subunit |
ISONIAZID |
Glycine, Strychnine-Sensitive |
-16% |
NoneNone |
NoneNone |
View
|
cathepsin G |
AMIODARONE |
Protease, Cathepsin G |
-16% |
NoneNone |
NoneNone |
View
|
mast cell protease 9 |
AMIODARONE |
Protease, Cathepsin G |
-16% |
NoneNone |
NoneNone |
View
|
matrix metalloproteinase 1 (interstitial collagenase) |
OMEPRAZOLE |
Protease, Matrix Metalloprotease-1 (MMP-1) |
-16% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 5 |
SULBACTAM |
Chemokine CCR5 |
-16% |
NoneNone |
NoneNone |
View
|
androgen receptor |
SULBACTAM |
Testosterone |
-16% |
NoneNone |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
SULFADOXINE |
Dopamine Transporter |
-16% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2C |
SULFADOXINE |
Serotonin 5-HT2C |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
SULFADOXINE |
Glutamate, NMDA, Phencyclidine |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, NMDA2C |
SULFADOXINE |
Glutamate, NMDA, Phencyclidine |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
SULFADOXINE |
Glutamate, NMDA, Phencyclidine |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
SULFADOXINE |
Glutamate, NMDA, Phencyclidine |
-16% |
NoneNone |
NoneNone |
View
|
N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) |
SULFADOXINE |
Glutamate, NMDA, Phencyclidine |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B |
SULFADOXINE |
Glutamate, NMDA, Phencyclidine |
-16% |
NoneNone |
NoneNone |
View
|
monoamine oxidase A |
NEOMYCIN |
Monoamine Oxidase MAOA |
-16% |
NoneNone |
NoneNone |
View
|
monoamine oxidase A |
NEOMYCIN |
Monoamine Oxidase MAOA |
-16% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 1a |
GOLD SODIUM THIOMALATE |
Adrenergic alpha1A |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
AMRINONE |
Glutamate, NMDA, Phencyclidine |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, NMDA2C |
AMRINONE |
Glutamate, NMDA, Phencyclidine |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
AMRINONE |
Glutamate, NMDA, Phencyclidine |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
AMRINONE |
Glutamate, NMDA, Phencyclidine |
-16% |
NoneNone |
NoneNone |
View
|
N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) |
AMRINONE |
Glutamate, NMDA, Phencyclidine |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B |
AMRINONE |
Glutamate, NMDA, Phencyclidine |
-16% |
NoneNone |
NoneNone |
View
|
neuropeptide Y receptor Y2 |
AMRINONE |
Neuropeptide Y2 |
-16% |
NoneNone |
NoneNone |
View
|
neuropeptide Y receptor Y2 |
AMRINONE |
Neuropeptide Y2 |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
ZOMEPIRAC |
Glutamate, NMDA, Phencyclidine |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
ZOMEPIRAC |
Glutamate, NMDA, Phencyclidine |
-16% |
NoneNone |
NoneNone |
View
|
N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) |
ZOMEPIRAC |
Glutamate, NMDA, Phencyclidine |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B |
ZOMEPIRAC |
Glutamate, NMDA, Phencyclidine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
ANISINDIONE |
Calcium Channel Type L, Dihydropyridine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
ANISINDIONE |
Calcium Channel Type L, Dihydropyridine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
ANISINDIONE |
Calcium Channel Type L, Dihydropyridine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
ANISINDIONE |
Calcium Channel Type L, Dihydropyridine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
ANISINDIONE |
Calcium Channel Type L, Dihydropyridine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
ANISINDIONE |
Calcium Channel Type L, Dihydropyridine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
ANISINDIONE |
Calcium Channel Type L, Dihydropyridine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
ANISINDIONE |
Calcium Channel Type L, Dihydropyridine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
ANISINDIONE |
Calcium Channel Type L, Dihydropyridine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
ANISINDIONE |
Calcium Channel Type L, Dihydropyridine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
ANISINDIONE |
Calcium Channel Type L, Dihydropyridine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
ANISINDIONE |
Calcium Channel Type L, Dihydropyridine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
ANISINDIONE |
Calcium Channel Type L, Dihydropyridine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
ANISINDIONE |
Calcium Channel Type L, Dihydropyridine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
ANISINDIONE |
Calcium Channel Type L, Dihydropyridine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
ANISINDIONE |
Calcium Channel Type L, Dihydropyridine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
ANISINDIONE |
Calcium Channel Type L, Dihydropyridine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
ANISINDIONE |
Calcium Channel Type L, Dihydropyridine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
ANISINDIONE |
Calcium Channel Type L, Dihydropyridine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
PENICILLIN G |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
PENICILLIN G |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
PENICILLIN G |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
PENICILLIN G |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
PENICILLIN G |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
PENICILLIN G |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
PENICILLIN G |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
PENICILLIN G |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
PENICILLIN G |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
PENICILLIN G |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
PENICILLIN G |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
PENICILLIN G |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
PENICILLIN G |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
PENICILLIN G |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
PENICILLIN G |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
PENICILLIN G |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
PENICILLIN G |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
PENICILLIN G |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
PENICILLIN G |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
progesterone receptor |
NOSCAPINE |
Progesterone |
-16% |
NoneNone |
NoneNone |
View
|
progesterone receptor |
NOSCAPINE |
Progesterone |
-16% |
NoneNone |
NoneNone |
View
|
bradykinin receptor, beta 2 |
SPARFLOXACIN |
Bradykinin B2 |
-16% |
NoneNone |
NoneNone |
View
|
bradykinin receptor B2 |
SPARFLOXACIN |
Bradykinin B2 |
-16% |
NoneNone |
NoneNone |
View
|
Protein-tyrosine kinase, Fyn |
SALSALATE |
Protein Tyrosine Kinase, Fyn |
-16% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor 2 |
SUXAMETHONIUM CHLORIDE |
Leukotriene B4 |
-16% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor |
SUXAMETHONIUM CHLORIDE |
Leukotriene B4 |
-16% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor |
SUXAMETHONIUM CHLORIDE |
Leukotriene B4 |
-16% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor 2 |
SUXAMETHONIUM CHLORIDE |
Leukotriene B4 |
-16% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3a |
SUXAMETHONIUM CHLORIDE |
Serotonin 5-HT3 |
-16% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3b |
SUXAMETHONIUM CHLORIDE |
Serotonin 5-HT3 |
-16% |
NoneNone |
NoneNone |
View
|
opioid receptor, kappa 1 |
NATEGLINIDE |
Opiate kappa |
-16% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 1B |
BAY 11-7085 |
Serotonin 5-HT1B |
-16% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 5B |
NIACIN |
Serotonin 5-HT4 |
-16% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 4 |
NIACIN |
Serotonin 5-HT4 |
-16% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 2 |
SUXAMETHONIUM CHLORIDE |
Chemokine CCR2B |
-16% |
NoneNone |
NoneNone |
View
|
melanocortin 5 receptor |
CLINDAMYCIN |
Melanocortin MC5 |
-16% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3a |
TIBOLONE |
Serotonin 5-HT3 |
-16% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3b |
TIBOLONE |
Serotonin 5-HT3 |
-16% |
NoneNone |
NoneNone |
View
|
calcitonin receptor |
AZTREONAM |
Calcitonin |
-16% |
NoneNone |
NoneNone |
View
|
bradykinin receptor, beta 2 |
SPIRONOLACTONE |
Bradykinin B2 |
-16% |
NoneNone |
NoneNone |
View
|
bradykinin receptor B2 |
SPIRONOLACTONE |
Bradykinin B2 |
-16% |
NoneNone |
NoneNone |
View
|
histamine receptor H 2 |
CLONAZEPAM |
Histamine H2 |
-16% |
NoneNone |
NoneNone |
View
|
interleukin 8 receptor, alpha |
CLOPIDOGREL |
Chemokine CXCR1(IL-8A) |
-16% |
NoneNone |
NoneNone |
View
|
insulin receptor |
FAMOTIDINE |
Insulin |
-16% |
NoneNone |
NoneNone |
View
|
insulin receptor |
FAMOTIDINE |
Insulin |
-16% |
NoneNone |
NoneNone |
View
|
interleukin 8 receptor, alpha |
TIBOLONE |
Chemokine CXCR1(IL-8A) |
-16% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 1 |
CANTHARIDIN |
Protein Serine/Threonine Kinase, ERK2 |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
PANTOPRAZOLE |
Calcium Channel Type L, Benzothiazepine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
PANTOPRAZOLE |
Calcium Channel Type L, Benzothiazepine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
PANTOPRAZOLE |
Calcium Channel Type L, Benzothiazepine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
PANTOPRAZOLE |
Calcium Channel Type L, Benzothiazepine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
PANTOPRAZOLE |
Calcium Channel Type L, Benzothiazepine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
PANTOPRAZOLE |
Calcium Channel Type L, Benzothiazepine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
PANTOPRAZOLE |
Calcium Channel Type L, Benzothiazepine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
PANTOPRAZOLE |
Calcium Channel Type L, Benzothiazepine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
PANTOPRAZOLE |
Calcium Channel Type L, Benzothiazepine |
-16% |
NoneNone |
NoneNone |
View
|
DNA encoding receptor of vasoactive intestinal polypeptide |
CHLORMADINONE ACETATE |
Vasoactive Intestinal Peptide VIP1 |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-2C19 monooxygenase |
AMINOCAPROIC ACID |
CYP450-2C19 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
dopamine receptor D4 |
CLENBUTEROL |
Dopamine D4.2 |
-20% |
NoneNone |
NoneNone |
View
|
synaptic vesicle glycoprotein 2b |
CHLORMADINONE ACETATE |
beta-Lactamase |
-20% |
NoneNone |
NoneNone |
View
|